The rate of MS in the AA group for rs2479106 in DENND1A, and the GG+GT group for rs4784165 in TOX3, were all slightly higher than that in another genotype group using dominant/recessive model (26.4 vs. 22.9%, P = 0.066; 26.3 vs. 22.7%, P = 0.068, Table 3). This evidence concerns the gene TOX3 and myeloid sarcoma.